FDA Inspection
Sinopharm Weiqida Pharmaceutical Co. Ltd.Sinopharm Weiqida Pharmaceutical Co. Ltd. – FDA Inspection, May 25, 2023
Record Details
This FDA Inspection record concerns Sinopharm Weiqida Pharmaceutical Co. Ltd., with an inspection on May 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b4ad5182-3f8a-40cb-afd1-d9e89487b422
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1209420
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sinopharm Weiqida Pharmaceutical Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 1, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sinopharm Weiqida Pharmaceutical Co. Ltd.
- FDA Inspection 1028876 - 2017-07-21
- FDA Inspection 932412 - 2015-05-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.